跳至主要内容
临床试验/NCT06661174
NCT06661174招募中不适用

A Cohort Study on the Efficacy of Bariatric Surgery for Rapidly Progressing Diabetic Nephropathy

China-Japan Friendship Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100
试验地点
1
主要终点
Total weight loss

研究概览

简要总结

Establish a cohort of diabetic kidney disease(DKD) patients with intensive weight loss treatment to evaluate the impact of intensive weight loss treatment on the renal prognosis of DKD and construct a prediction model for the improvement of renal outcomes after weight loss.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 to 65 years old;
  • BMI>25Kg/m2 or abdominal obesity (i.e. waist circumference>90cm for men and>85cm for women);
  • eGFR<30ml/min/1.73m2 or urinary microalbumin≥300mg/g, eGFR<60ml/min/1.73m2.

排除标准

  • Patients who are taking glucocorticoids;
  • Combined with tumors; ③Combined with autoimmune diseases; ④Serum albumin<25g/L.

结局指标

主要结局

Total weight loss

时间窗: 1st, 3rd, 6th and 12th month after intervention, respectively.

次要结局

  • Serum creatinine(1st, 3rd, 6th and 12th month after intervention, respectively.)
  • Glomerular filtration rate(1st, 3rd, 6th and 12th month after intervention, respectively.)
  • Fasting blood glucose(1st, 3rd, 6th and 12th month after intervention, respectively.)
  • Average blood glucose from continuous glucose monitoring(1st, 3rd, 6th and 12th month after intervention, respectively.)
  • Postprandial 2-hour blood glucose(1st, 3rd, 6th and 12th month after intervention, respectively.)
  • HbA1c(1st, 3rd, 6th and 12th month after intervention, respectively.)
  • Waist circumference and hip circumference(1st, 3rd, 6th and 12th month after intervention, respectively.)
  • Urinary microalbumin and other Urinalysis indexes(1st, 3rd, 6th and 12th month after intervention, respectively.)
  • Medication status(1st, 3rd, 6th and 12th month after intervention, respectively.)

研究者

发起方
China-Japan Friendship Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hua Meng

Director of the General Surgery Department & Obesity and Metabolic Disease Center of China-Japan Friendship Hospital

China-Japan Friendship Hospital

研究点 (1)

Loading locations...

相似试验